Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China

By Abnet C.C.  

Cancer Causes and Control, Vol. 12, Iss. 9, 2001-11 ,pp. : 821-828

Springer Publishing Company

Access to resources Recommend Favorite

Changes in Sensitivity of Cells during Exposure to Radiation at Low Dose-rate

By Bryant P.E.  

International Journal of Radiation Biology, Vol. 22, Iss. 1, 1972-07 ,pp. : 67-73

Informa Healthcare

Access to resources Recommend Favorite

Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma

By Treiber G.   Wex T.   Röcken C.   Fostitsch P.   Malfertheiner P.  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 699-708

Springer Publishing Company

Access to resources Recommend Favorite

Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves' disease

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 925-930

Spandidos Publications

Access to resources Recommend Favorite

Editorial (Hot Topic: Ductal Carcinoma in situ (DCIS) of the Breast, Biomarkers, Diagnosis, and Treatment of the Disease)

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-01 ,pp. : 161-161

Bentham Science Publishers

Access to resources Recommend Favorite